Product Information

NAPROXEN SOD CR 500 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $9.5851 per EA under NDC 24979025368. Its NADAC has been published 90 times since Dec 4, 2024.

FDA first approved this application on Jan 5, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Naproxen Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for NAPROXEN SOD CR 500 MG TABLET has been published 90 times since Dec 4, 2024, and over the history we have for it it has risen 3.8%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.